lifestyle.capitolhilltimes.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership

    ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership

    PRZen
    February 24, 2026
  • GoDaddy Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    GoDaddy Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    GoDaddy.com, LLC
    February 24, 2026
  • Arthur J. Gallagher & Co. Announces New Investor Relations Leader

    Arthur J. Gallagher & Co. Announces New Investor Relations Leader

    ARTHUR J. GALLAGHER & CO.
    February 24, 2026
  • Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call

    Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call

    DOCUSIGN, INC.
    February 24, 2026
  • Lucid Files Resale Prospectus Supplement

    Lucid Files Resale Prospectus Supplement

    LUCID MOTORS
    February 24, 2026
  • TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

    TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

    TransMedics Group, Inc.
    February 24, 2026
  • ClearView successfully implements Equisoft’s cloud-based policy administration system

    ClearView successfully implements Equisoft’s cloud-based policy administration system

    Equisoft Inc.
    February 24, 2026
  • Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference

    Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference

    Azenta, Inc.
    February 24, 2026
  • Gen to Present at the Morgan Stanley Technology, Media & Telecom Conference

    Gen to Present at the Morgan Stanley Technology, Media & Telecom Conference

    Gen Digital Inc.
    February 24, 2026
  • Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

    Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

    Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates
    February 24, 2026
Prev
1 … 6,851 6,852 6,853 6,854 6,855 … 30,740
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.